Two New Cases of 1p21.3 Deletions and an Unbalanced Translocation t(8;12) among Individuals with Syndromic Obesity.

Autor: D'Angelo CS; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Center, Institute of Biosciences, University of São Paulo, São Paulo, Brazil., Moller Dos Santos MF; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Center, Institute of Biosciences, University of São Paulo, São Paulo, Brazil., Alonso LG; Genetics Division, Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil., Koiffmann CP; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Center, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
Jazyk: angličtina
Zdroj: Molecular syndromology [Mol Syndromol] 2015 Jul; Vol. 6 (2), pp. 63-70. Date of Electronic Publication: 2015 Jan 28.
DOI: 10.1159/000371600
Abstrakt: Obesity is a highly heritable but genetically heterogeneous disorder. Various well-known microdeletion syndromes (e.g. 1p36, 2q37, 6q16, 9q34, 17p11.2) can cause this phenotype along with intellectual disability (ID) and other findings. Chromosomal microarrays have identified 'new' microdeletion/duplication syndromes often associated with obesity. We report on 2 unrelated patients with an overlapping region of deletion at 1p21.3p21.2, and a third patient with a de novo recurrent unbalanced translocation der(8)t(8;12)(p23.1;p13.31), detected by 180K array CGH in a prospective cohort of syndromic obesity patients. Deletion of 1p21.3 is a rare condition, and there have been only 11 cases of the same recurrent translocation between chromosomes 8 and 12 [t(8;12)] reported to date. The former has been associated with ID, autistic spectrum disorder (ASD) and mild dysmorphic features, and in 4 patients who were obese or had a tendency to obesity, a minimal overlapping region of 2 genes, DPYD and MIR137, was detected; t(8;12) has recently been recognized to cause a childhood obesity syndrome due to duplication of the GNB3 gene. Thus, our findings add to the existing literature on the clinical description of these new syndromes, providing additional support that these loci are associated with syndromic obesity. We suggest that heterozygous loss of MIR137 may contribute to obesity as well as ID and ASD.
Databáze: MEDLINE